Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Yearbook of Cardiology CrossRef

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study

Cheitlin, M.D.
Yearbook of Cardiology , Volume 2012: 340-342 – Jan 1, 2012
Download PDF

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study

Cheitlin, M.D.
Yearbook of Cardiology , Volume 2012: 340-342 – Jan 1, 2012

Loading next page...
 
/lp/crossref/pulmonary-hypertension-in-heart-failure-with-preserved-ejection-M2oSVZgYd6

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
CrossRef
ISSN
0145-4145
DOI
10.1016/j.ycar.2012.01.055
Publisher site
See Article on Publisher Site

Abstract

Journal

Yearbook of Cardiology – CrossRef

Published: Jan 1, 2012

References

  • Trends in prevalence and outcome of heart failure with preserved ejection fraction
    Owan
  • Outcome of heart failure with preserved ejection fraction in a population-based study
    Bhatia
  • Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
    Ghio
  • Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study
    Lam
  • The impact of finally publishing a negative study: new conclusions about endothelin antagonists
    Gottlieb
  • A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST)
    Califf
  • Pulmonary hypertension with left-sided heart disease
    Guazzi
  • Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure
    Delgado
  • Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management
    Moraes
  • Long-term use of sildenafil in the therapeutic management of heart failure
    Guazzi
  • The role of the pulmonary vasculature in heart failure with preserved ejection fraction
    Lewis
  • Clinical use of phoshodiesterase-5 inhibitors in chronic heart failure
    Guazzi
  • PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry and clinical status in patients with stable systolic heart failure: results of a 1-year prospective, randomized, placebo-controlled study
    Guazzi
  • Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study
    Guazzi